| |
| |
|
| Insider
Information: |
Higgins John L |
| Relationship: |
Director |
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,806,928 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$48,561,124 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
2,806,928 |
|
|
| Total
Value |
$48,561,124 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
11
|
|
Stock
price went up :
|
0
|
5
|
| Stock
price went down : |
0
|
6
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -38.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ligand Pharmaceuticals Inc |
LGND |
Director |
2022-12-28 |
417,695 |
2007-02-01 |
0 |
Premium* |
|
|
Techne Corp |
TECH |
Director |
2024-05-14 |
36,608 |
2013-10-31 |
0 |
Premium* |
|
|
OmniAb, Inc |
OABI |
Director |
2024-01-30 |
2,352,625 |
2022-11-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
165 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2019-12-20 |
4 |
A |
$0.00 |
$0 |
D/D |
13,614 |
156,562 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2020-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
13,559 |
210,289 |
0 |
- |
|
| TECH |
Techne Corp |
|
– • – |
2020-10-29 |
4 |
A |
$0.00 |
$0 |
D/D |
391 |
4,412 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2021-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
15,553 |
248,018 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2021-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
12,608 |
286,030 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
23,166 |
358,261 |
0 |
- |
|
| TECH |
Techne Corp |
|
– • – |
2022-10-27 |
4 |
A |
$0.00 |
$0 |
D/D |
338 |
5,840 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Director |
– • – |
2022-11-01 |
4/A |
A |
$0.00 |
$0 |
D/D |
2,427,861 |
2,603,965 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Director |
– • – |
2022-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,176,521 |
2,176,521 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
45,922 |
424,731 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Director |
– • – |
2023-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
39,517 |
2,462,686 |
0 |
- |
|
| TECH |
Techne Corp |
Director |
– • – |
2023-10-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,625 |
36,608 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Director |
– • – |
2024-01-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,173 |
2,352,625 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2009-12-31 |
4 |
A |
$1.84 |
$2,099 |
D/D |
1,138 |
333,138 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2010-12-31 |
4 |
A |
$7.14 |
$2,099 |
D/D |
294 |
73,788 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2010-06-30 |
4 |
A |
$1.24 |
$2,100 |
D/D |
1,692 |
440,968 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2011-06-30 |
4 |
A |
$7.64 |
$2,116 |
D/D |
277 |
89,065 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2011-12-30 |
4 |
A |
$10.09 |
$2,119 |
D/D |
210 |
89,275 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Director |
– • – |
2023-05-19 |
4 |
OE |
$3.68 |
$3,680 |
D/D |
1,000 |
2,463,686 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Director |
– • – |
2023-05-19 |
4 |
S |
$4.05 |
$4,050 |
D/D |
(1,000) |
2,462,686 |
0 |
% |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2012-08-13 |
4 |
B |
$16.39 |
$8,195 |
D/D |
500 |
110,025 |
2.81 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2010-02-17 |
4 |
B |
$1.67 |
$10,020 |
D/D |
6,000 |
439,276 |
2.81 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2007-08-13 |
4 |
B |
$5.86 |
$11,720 |
D/D |
2,000 |
154,000 |
2.81 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2012-05-04 |
4 |
B |
$12.04 |
$12,040 |
D/D |
1,000 |
108,275 |
2.81 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-06-30 |
4 |
A |
$75.84 |
$12,437 |
D/D |
164 |
369,180 |
0 |
- |
|
165 Records found
|
|
Page 2 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
